VerifiedBiotechnology Research

Delphia Therapeutics

Delphia Therapeutics is a biotechnology company pioneering activation lethality, a new area of cancer therapeutics that target cancer's surprising vulnerability to oncogene overactivation. Delphia’s activation lethality platform offers the potential for first-in-class targeted cancer medicines that are effective on their own while also combating the emergence of drug resistance to classic targeted therapies.

7-day free trial · no credit card

Cambridge, United States29(11 to 50)delphiatx.com LinkedIn

Verified contacts

26

available on Kipplo

LinkedIn employees

29

11 to 50 range

Open roles

—

no listings

Distinct roles

13

indexed titles

Tech stack

0

tools in use

Monthly traffic

—

organic / mo

Sign up free to see all 26 verified contacts at Delphia Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Decision-makers and verified team members

26 contacts with verified email or phone · masked until revealed.

Sign up free →

Showing 9 of 26 verified contacts

Top roles at Delphia Therapeutics

13 distinct titles indexed · top 10 shown.

4()
1associate director principal scientist, pharmacology
1associate director, program management
1co-founder
1director
1director, biochemistry
1executive assistant
1northeastern university college of science
1principal scientist, cell biology
1senior research associate
+3more titles

Sign up to unlock all 26 contacts at Delphia Therapeutics

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up to reveal 26 verified contacts at Delphia Therapeutics

7-day trial · no credit card · cancel anytime · only pay for verified records.

Sign up free See pricing

Trusted by sales, marketing, and GTM engineering teams.

Delphia Therapeutics | Kipplo Discover